Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Jarvis

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
European Journal of Pharmacology|February 5, 2000
ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic painM F Jarvis, J L Wessale, C Z Zhu, et al.
Journal of Medicinal Chemistry|July 1, 1990
2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligandsA J Hutchison, M Williams, R de Jesus, et al.
European Journal of Pharmacology|August 10, 1999
Pharmacological characterization of recombinant human and rat P2X receptor subtypesB R Bianchi, K J Lynch, E Touma, et al.
Journal of Medicinal Chemistry|June 19, 2001
Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitorC H Lee, M Jiang, M Cowart, et al.
Journal of Medicinal Chemistry|December 22, 2000
Design of adenosine kinase inhibitors from the NMR-based screening of fragmentsP J Hajduk, A Gomtsyan, S Didomenico, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the ratE A Kowaluk, J Mikusa, C T Wismer, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2001
Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitorsM Cowart, C H Lee, G A Gfesser, et al.
Neuroscience|May 5, 2007
P2X7-related modulation of pathological nociception in ratsS McGaraughty, K L Chu, M T Namovic, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Pyridopyrimidine analogues as novel adenosine kinase inhibitorsG Z Zheng, C Lee, J K Pratt, et al.
British Journal of Pharmacology|February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overviewStephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
European Journal of Pharmacology|February 5, 2000
ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic painM F Jarvis, J L Wessale, C Z Zhu, et al.
Journal of Medicinal Chemistry|July 1, 1990
2-(Arylalkylamino)adenosin-5'-uronamides: a new class of highly selective adenosine A2 receptor ligandsA J Hutchison, M Williams, R de Jesus, et al.
European Journal of Pharmacology|August 10, 1999
Pharmacological characterization of recombinant human and rat P2X receptor subtypesB R Bianchi, K J Lynch, E Touma, et al.
Journal of Medicinal Chemistry|June 19, 2001
Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitorC H Lee, M Jiang, M Cowart, et al.
Journal of Medicinal Chemistry|December 22, 2000
Design of adenosine kinase inhibitors from the NMR-based screening of fragmentsP J Hajduk, A Gomtsyan, S Didomenico, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the ratE A Kowaluk, J Mikusa, C T Wismer, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2001
Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitorsM Cowart, C H Lee, G A Gfesser, et al.
Neuroscience|May 5, 2007
P2X7-related modulation of pathological nociception in ratsS McGaraughty, K L Chu, M T Namovic, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Pyridopyrimidine analogues as novel adenosine kinase inhibitorsG Z Zheng, C Lee, J K Pratt, et al.
British Journal of Pharmacology|February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overviewStephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
Pageof 8